Additionally, studies have shown that PLK1 can promote the progression and metastasis of clear cell renal cell carcinoma by upregulating hypoxia-inducible factor 2, which transcriptionally targeting the hypoxia-responsive element of the PLK1 promoter (55). The gene discussed is PLK1; the disease is clear cell renal carcinoma.